Skip to content

Study · Case report or series · n = 1 · 2004

3 results

Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue.

Burke C, Hickey K

Obstetrics and gynecology1 Nov 2004Cited by 32 (Europe PMC)

PMID15516445 (opens in a new tab)DOI10.1097/01.aog.0000133533.05148.aa (opens in a new tab)PepBankPUB-15516445
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In a woman with endometrial stromal sarcoma, triptorelin before surgery reduced uterine size.

    In plain wordsIn a woman with endometrial stromal sarcoma, triptorelin before surgery reduced uterine size.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    DecreaseUterine size before surgery
    Study

    n = 1

    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Treatment with the gonadotropin-releasing hormone (GnRH) analogue triptorelin before surgery had produced reduction in uterine size.
    1 context sentence
    Summary · context
    A woman who underwent myomectomy was discovered to have a low-grade endometrial stromal sarcoma.
  2. 02HumanCase report or seriesEfficacy outcome

    In a woman with recurrent endometrial stromal sarcoma, repeat triptorelin administration accompanied resolution of hydronephrosis.

    In plain wordsIn a woman with recurrent endometrial stromal sarcoma, repeat triptorelin administration accompanied resolution of hydronephrosis.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    DecreaseHydronephrosis at recurrence
    Study

    n = 1

    Outcome group
    Kidney function · Kidney and urinary
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Repeat administration of triptorelin was accompanied by resolution of the hydronephrosis and reduction in tumor volume.
    1 context sentence
    Summary · context
    A woman who underwent myomectomy was discovered to have a low-grade endometrial stromal sarcoma.
  3. 03HumanCase report or seriesEfficacy outcome

    In a woman with recurrent endometrial stromal sarcoma, repeat triptorelin administration accompanied reduced tumor volume.

    In plain wordsIn a woman with recurrent endometrial stromal sarcoma, repeat triptorelin administration accompanied reduced tumor volume.

    Peptide
    Triptorelin (Trelstar, Decapeptyl)
    Outcome
    DecreaseTumor volume at recurrence
    Study

    n = 1

    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Repeat administration of triptorelin was accompanied by resolution of the hydronephrosis and reduction in tumor volume.
    1 context sentence
    Summary · context
    A woman who underwent myomectomy was discovered to have a low-grade endometrial stromal sarcoma.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.